Menopause affects pain depending on pain type and characteristics

Menopause

Volumn 19, Issue 5, 2012, Pages 517-523

  Meriggiola, Maria Cristina ^a   Nanni, Michela ^a   Bachiocco, Valeria ^b   Vodo, Stellina ^b   Aloisi, Anna M ^b,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c San Carlo Clinic   (Italy)

Author keywords

Menopause; Pain questionnaires; Pain syndromes

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTHRALGIA; ARTICLE; BONE PAIN; CERVICAL PAIN; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MENOPAUSE; OBSERVATIONAL STUDY; PAIN; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; VISCERAL ABDOMINAL PAIN;

ABDOMINAL PAIN; ARTHRALGIA; BACK PAIN; CHRONIC PAIN; CLUSTER ANALYSIS; FEMALE; FIBROMYALGIA; HEADACHE; HUMANS; MENOPAUSE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRES; RECURRENCE; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 84860745213     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318240fe3d     Document Type: Article

References (40)

1. Brown TH, Chapman PF, Kairiss EW, Keenan CL. Long-term synaptic potentiation. Science 1988;242:724-728.
2. Phillips SM, Sherwing BB. Variation in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 1992;17: 497-506.
3. Blair HT, Schafe GE, Bauer EP, Rodrigues SM, LeDoux JE. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 2001;8:229-242.
4. Meisler JG. Chronic pain conditions in women. J Womens Health 1999;8: 313-320.
5. RCGP Birmingham Research Unit, Annual Prevalence Report 2006.
6. Aloisi AM, Bonifazi M. Sex hormones, central nervous system and pain. Horm Behav 2006;50:1-7.
7. Greenspan JD, Craft RM, LeResche L, et al; Consensus Working Group of the Sex, Gender, and Pain SIG of the IASP. Studying sex and gender differences in pain and analgesia: a consensus report Pain 2007;132: S26-S45.
8. Freeman EW, Sammel MD, Lin H, Gracia CR, Kapoor S. Symptoms in the menopausal transition: hormones and behavioral correlates. Obstet Gynecol 2008;111:127-136.
9. Craft RM, Mogil JS, Aloisi AM. Sex differences in pain and analgesia: the role of gonadal hormones. Eur J Pain 2004;8:397-411.
10. Aloisi AM, Affaitati G, Ceccarelli I, et al. Estradiol and testosterone differently affect visceral pain-related behavioural responses in male and female rats. Eur J Pain 2010;14:602-607.
11. Fillingim RB, Maixner W. Gender differences in the responses to noxious stimuli. Pain Forum 1995;4:209-221.
12. Smith YR, Stohler CS, Nichols TE, Bueller JA, Koeppe RA, Zubieta JK. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci 2006;26:5777-5785.
13. Aloisi AM, Bachiocco V, Costantino A, et al. Cross-sex hormone administration changes pain in transsexual women and men. Pain 2007;132: S60-S67.
14. Graham JR, Lilly RS, eds. Psychological Testing. Englewood Cliffs, NJ: Prentice Hall, Inc, 1984.
15. Margolis RB, Tait RC, Krause SJ. A rating system for use with patients pain drawings. Pain 1986;24:57-65.
16. Margolis RB, Chibnall JT, Tait RC. Test-retest reliability of the pain drawing instrument. Pain 1988;33:49-51.
17. Jensen MP, Karoly P. Self-report scales and procedures for assessing pain in adults. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York, NY: Guilford Press, 2001:135-151.
18. Huskisson EC. Visual analog scales. In: Melzack R, ed. Pain Measurements and Assessment. New York, NY: Raven Press, 1983:33-37.
19. Guy W. ECDEU Assessment Manual for Psychopharmacology (DHEW Publication No. ADM 76-338). Washington, DC: US Government Printing Office, 1976.
20. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
21. Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical rating scale. Pain 2001;94:149-158.
22. Melzack R. The McGill Pain Questionnaire: major properties and scoring methods. Pain 1975;1:277-299.
23. Melzack R, Katz J. The McGill Pain Questionnaire: appraisal and current status. In: Turk DC, Melzack R, eds. Handbook of Pain Assessment. New York, NY: Guilford Press, 2001:659-692.
24. Maiani G, Sanavio E. Semantics of pain in Italy: the Italian version of the McGill Pain Questionnaire. Pain 1985;22:399-405.
25. Maiani G, Sanavio E. McGill Pain Questionnaire. Manuale per la versione Italiana. Fondazione SM IRCCS. Montescano, 1989.
26. Giamberardino MA, ed. Visceral Pain: Clinical, Pathophysiological and Therapeutic Aspects. Oxford, UK: Oxford University Press, 2009.
27. Kuettner KE, Goldberg VM, eds. Osteoarthritic Disorders. Rosemont, IL: American Academy of Orthopaedic Surgeons, 1995.
28. Wolfe FW, Smythe HA, Yunas MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33: 160-172.
29. Fillingim RB. Sex, Gender and Pain. Progress in Pain Research and Management. Vol 17. Seattle, WA: IASP Press, 2000.
30. Riley JL, Robinson ME, Wise EA, Price D. A meta-analytic review of pain perception across the menstrual cycle. Pain 1999;81:225-235.
31. Cuzick J, Sestalk I, Cella D. Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial. Lancet Oncol 2008;9:1143-1148.
32. Yu SB, Wang MQ, Li YQ, et al. The effects of age and sex on the expression of oestrogen and its receptors in rat mandibular condylar cartilages. Arch Oral Biol 2009;54:479-485.
33. Ng KP, Datuin JP, Bern HA. Effects of estrogens in vitro and in vivo on cartilage growth in the tilapia (Oreochromis mossambicus). Gen Comp Endocrinol 2001;121:295-304.
34. Fernihough JK, Richmond RS, Carlson CS. Estrogen replacement therapy modulation of the insulin-like growth factor system in monkey knee joints. Arthritis Rheum 1999;42:2103-2111.
35. Da Silva JA, Colville-Nash P, Spector TD, Scott DL, Willoughby DA. Inflammation-induced cartilage degradation in female rodents. Protective role of sex hormones. Arthritis Rheum 1993;36:1007-1013.
36. Kramer PR, Winger V, Kramer SF. 17A-Estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes. Mol Cell Endocrinol 2007;279:16-25.
37. Kapila S, Wang W, Uston K. MMP induction by relaxin causes cartilage matrix degradation in target synovial joints: receptor profiles correlate with matrix turnover. Ann N Y Acad Sci 2009;1160:322-328.
38. Calabrese DC, Konop R, Cannon E, et al. Discussion. Treatment algorithm: managing rheumatoid arthritis. Manag Care 2001;10:19-24.
39. Somerville BW. The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 1972;22:355-365.
40. Davies P, Fursdon-Davies C, Rees MC. Progestogens for menstrual migraine, J Br Menopause Soc 2003;9:134.